Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02364999
Title	A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
Recruitment	Completed
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Pfizer
Indications	lung non-small cell carcinoma
Therapies	Bevacizumab + Carboplatin + Paclitaxel
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| ROU \| POL \| NLD \| ITA \| HUN \| HRV \| GRC \| FRA \| ESP \| DEU \| CZE \| BRA \| BGR \| AUS